X
Consumer Staples, Healthcare, Automotive Aug 19, 2021 06:47 PM (GMT+8) · EqualOcean
Financial Associated Press, August 19 - shutaishen announced that the bdb-001 injection applied by the company and its wholly-owned subsidiary Defeng Rui for the treatment of ANCA related vasculitis has been implicitly approved by the new drug clinical trial.